Cost-effective strategies for CAR-T cell therapy manufacturing

Cost-effective strategies for CAR-T cell therapy manufacturing

CAR-T cell therapy has revolutionized cancer treatment, with approvals for conditions like acute B-leukemia, large B cell lymphoma (LBCL), follicular lymphoma (FL), mantle cell lymphoma (MCL), and multiple myeloma. However, its high costs limit accessibility. Key factors driving these costs include...

Full description

Saved in:
Bibliographic Details
Main Authors: Luiza Abdo, Leonardo Ribeiro Batista-Silva, Martín Hernán Bonamino
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Molecular Therapy: Oncology
Subjects:
MT: Regular Issue
CAR-T cell
cost-effective
immunotherapy
manufacturing
B cell tumor
Online Access:http://www.sciencedirect.com/science/article/pii/S2950329925000499
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items